| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0228801759885687 | 0.37405859 |
| NSC 748715 | Null | 0.0228801759885687 | 0.24515793 |
| NSC 754245 | 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione | 0.0228801759885687 | 0.07722726 |
| NSC 87364 | Null | 0.0228801759885687 | 0.26377491 |
| NSC 119915 | 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid | 0.0238174255956147 | 0.27012865 |
| NSC 135880 | Null | 0.0238174255956147 | 0.33837992 |
| NSC 154948 | M-AMSA | 0.0238174255956147 | 0.35652636 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0238174255956147 | 0.22409306 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0238174255956147 | 0.2398045 |
| NSC 244404 | Null | 0.0238174255956147 | 0.12682923 |